Abnormal Mucosal Associated Invariant T Cell Proportion Cn381931
A condition involving abnormal proportions of a specific type of immune cell called mucosal associated invariant T cells. These cells play a role in immune defense. It may be associated with immune disorders and typically requires evaluation by an immunology specialist.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(immunologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Mucosal infections
(immunologic)Gastrointestinal discomfort
(immunologic)Oral ulcers
(immunologic)Fever of unknown origin
(immunologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Immunological Assessment
Regular monitoring of MAIT cell populations through flow cytometry to track changes and identify underlying immunological patterns requiring intervention.
Immunonutrition Support
Targeted nutritional approach emphasizing vitamins A, D, and B6 along with zinc to support healthy immune cell development and function.
Additional treatment options
Stress Reduction Program
Implementation of stress management techniques including mindfulness and relaxation training to optimize immune function through neuroendocrine regulation.
lifestyleVitamin D Supplementation
Supplementation to maintain optimal vitamin D levels, which are essential for proper immune cell maturation and function.
complementaryTreatment of Underlying Cause
If an underlying condition affecting MAIT cell populations is identified, targeted medication management addressing the primary etiology.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Mucosal Associated Invariant T Cell Proportion Cn381931?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Godfrey DI, Uldrich AP, McCluskey J, Rossjohn J. The burgeoning family of unconventional T cells. Nat Immunol. 2015.
International Union of Immunological Societies. Primary Immunodeficiency Report 2020. Front Immunol. 2021.
Le Bourhis L, Dusseaux M, Bohineust A, Couedelic B, Bhiddan F. MAIT cell activation in human bacterial infections. J Clin Invest. 2019.
Shaler CR, Cho D, Tang J, Kapp J. Mucosal-associated invariant T cells in health and disease: A systematic review. Clin Immunol. 2022.
Medication Comparisons
Compare medications used to treat Abnormal Mucosal Associated Invariant T Cell Proportion Cn381931. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy